WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2017191532) PHARMACEUTICAL FOAM COMPOSITION
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.:    WO/2017/191532    International Application No.:    PCT/IB2017/052397
Publication Date: 09.11.2017 International Filing Date: 26.04.2017
IPC:
A61K 9/107 (2006.01), A61K 8/362 (2006.01), A61Q 19/00 (2006.01), A61Q 19/02 (2006.01), A61K 47/06 (2006.01), A61K 47/08 (2006.01), A61K 47/10 (2017.01), A61K 47/12 (2006.01), A61K 47/14 (2017.01), A61K 47/20 (2006.01), A61K 9/12 (2006.01), A61K 31/20 (2006.01)
Applicants: GLENMARK PHARMACEUTICALS S.A. [CH/CH]; Vice President Intellectual Property Management & GPPM Glenmark Pharmaceutical limited Plot No.A-607, T.T.C Industrial Area M.I.D.C., Mahape Navi Mumbai 400 709 (CH)
Inventors: DHUPPAD, Ulhas; (IN).
PATLOLLA, Ram Reddy; (IN).
PATRO, Bikash Kumar; (IN).
BOMMAGANI, Madhusudan; (IN).
DABRE, Rahul; (IN)
Priority Data:
201621015520 04.05.2016 IN
Title (EN) PHARMACEUTICAL FOAM COMPOSITION
(FR) COMPOSITIONS DE MOUSSE PHARMACEUTIQUE
Abstract: front page image
(EN)The present invention relates to azelaic acid foam compositions comprising surfactants, a hydrophobic base, solvent and a propellant, which upon release from the aerosol container forms a stable foam product. The invention also relates to topical or mucosal administration of foamable compositions in treating dermatological disorders such as rosacea.
(FR)La présente invention concerne des compositions de mousse d'acide azélaïque comprenant des tensioactifs, une base hydrophobe, un solvant et un propulseur et qui, lors de leur libération depuis un contenant d'aérosol, forment un produit de mousse stable. L'invention concerne également l'administration, par voie topique ou par les muqueuses, de compositions expansibles dans le traitement de troubles dermatologiques tels que la rosacée.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)